ANI Pharmaceuticals, Inc. (ANIP)

Market Cap	1.36B
Revenue (ttm)	486.82M
Net Income (ttm)	17.15M
Shares Out	20.98M
EPS (ttm)	0.85
PE Ratio	75.98
Forward PE	14.18
Dividend	n/a
Ex-Dividend Date	n/a

Volume	34,271
Open	64.20
Previous Close	64.58
Day's Range	64.20 - 65.24
52-Week Range	36.99 - 70.81
Beta	0.80
Analysts	Strong Buy
Price Target	72.25 (+11.14%)
Earnings Date	May 10, 2024

About ANIP

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmac...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2001
• Employees: 642
• Stock Exchange: NASDAQ
• Ticker Symbol: ANIP

Analyst Forecast

According to 5 analysts, the average rating for ANIP stock is "Strong Buy." The 12-month stock price forecast is $72.25, which is an increase of 11.14% from the latest price.

Price Target

$72.25

(11.14% upside)

Analyst Consensus: Strong Buy